IVDA · Iveda Solutions, Inc. · Insider Trading
The latest filing states the doubt was alleviated.
“As of the issuance date of these financial statements, management expects that the Company’s cash of $4.8 million at June 30, 2026, will be sufficient to fund the Company’s current operating plan for at least twelve months from the date of issuance of these financial statements.”View the 10-Q filed Aug 14, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-02-23 | Franco Alejandro |
Director |
Award↑
Filing footnotes — Options (Right to Buy) (Direct)
On February 23, 2026, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $0.29 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. |
Options (Right to Buy)
|
25,000 |
| 2026-02-23 | BRILON ROBERT J |
Director, Chief Financial Officer |
Award↑
Filing footnotes — Options (Right to Buy) (Direct)
On February 23, 2026, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $0.29 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. |
Options (Right to Buy)
|
125,000 |
| 2026-02-23 | Ly David H. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Options (Right to Buy) (Direct)
On February 23, 2026, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $0.29 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. |
Options (Right to Buy)
|
175,000 |
| 2026-02-23 | Farnsworth Joseph A. |
Director |
Award↑
Filing footnotes — Options (Right to Buy) (Direct)
On February 23, 2026, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $0.29 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. |
Options (Right to Buy)
|
100,000 |
| 2026-02-23 | Gillen Robert |
Director |
Award↑
Filing footnotes — Options (Right to Buy) (Direct)
On February 23, 2026, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $0.29 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. |
Options (Right to Buy)
|
100,000 |
| 2025-12-29 | Ly David H. |
Director, Chief Executive Officer |
Other↑
|
Options (Right to Buy)
|
175,000 |
| 2025-12-29 | BRILON ROBERT J |
Director, Chief Financial Officer |
Other↑
|
Options (Right to Buy)
|
125,000 |
| 2025-12-29 | Gillen Robert |
Director |
Other↑
|
Options (Right to Buy)
|
100,000 |
| 2025-12-29 | Farnsworth Joseph A. |
Director |
Award↑
|
Options (Right to Buy)
|
100,000 |
| 2025-12-29 | Farnsworth Joseph A. |
Director |
Other↑
|
Options (Right to Buy)
|
100,000 |
| 2025-12-29 | Franco Alejandro |
Director |
Other↑
|
Options (Right to Buy)
|
25,000 |
| 2025-12-29 | Franco Alejandro |
Director |
Award↑
|
Options (Right to Buy)
|
25,000 |
| 2025-12-29 | Gillen Robert |
Director |
Award↑
|
Options (Right to Buy)
|
100,000 |
| 2025-12-29 | Ly David H. |
Director, Chief Executive Officer |
Award↑
|
Options (Right to Buy)
|
175,000 |
| 2025-12-29 | BRILON ROBERT J |
Director, Chief Financial Officer |
Award↑
|
Options (Right to Buy)
|
125,000 |
| 2025-10-21 | Gillen Robert |
Director |
Other↓
|
Common Stock
|
20,331 |
| 2024-12-05 | Farnsworth Joseph A. |
Director |
Award↑
|
Options (Right to Buy)
|
15,000 |
| 2024-12-05 | Ly David H. |
Director, Chief Executive Officer |
Award↑
|
Options (Right to Buy)
|
15,000 |
| 2024-12-05 | BRILON ROBERT J |
Director, Chief Financial Officer |
Award↑
|
Options (Right to Buy)
|
15,000 |
| 2024-12-05 | Franco Alejandro |
Director |
Award↑
|
Options (Right to Buy)
|
15,000 |
| 2024-12-05 | Gillen Robert |
Director |
Award↑
|
Options (Right to Buy)
|
15,000 |
| 2023-11-03 | BRILON ROBERT J |
Director, Chief Financial Officer |
Award↑
|
Options (Right to Buy)
|
60,000 |
| 2023-11-03 | Ly David H. |
Director, Chief Executive Officer |
Award↑
|
Options (Right to Buy)
|
70,000 |
| 2023-11-03 | Sung Chi-Kuang Sid |
President |
Award↑
|
Options (Right to Buy)
|
6,250 |
| 2023-11-03 | Farnsworth Joseph A. |
Director |
Award↑
|
Options (Right to Buy)
|
50,000 |
| 2023-11-03 | Omi Gregory |
Chief Technology Officer |
Award↑
|
Options (Right to Buy)
|
6,250 |
| 2023-11-03 | Gillen Robert |
Director |
Award↑
|
Options (Right to Buy)
|
50,000 |
| 2023-11-03 | Franco Alejandro |
Director |
Award↑
|
Options (Right to Buy)
|
50,000 |
| 2022-12-22 | Farnsworth Joseph A. |
Director |
Buy↑
|
Common Stock
|
4,200 |
| 2022-12-01 | Omi Gregory |
Chief Technology Officer |
Award↑
|
Options (Right to Buy)
|
6,250 |
| 2022-12-01 | Franco Alejandro |
Director |
Award↑
|
Options (Right to Buy)
|
6,250 |
| 2022-12-01 | BRILON ROBERT J |
Director, Chief Financial Officer |
Award↑
|
Options (Right to Buy)
|
12,500 |
| 2022-12-01 | Farnsworth Joseph A. |
Director |
Award↑
|
Options (Right to Buy)
|
10,000 |
| 2022-12-01 | Sung Chi-Kuang Sid |
President |
Award↑
|
Options (Right to Buy)
|
6,250 |
| 2022-12-01 | Gillen Robert |
Director |
Award↑
|
Options (Right to Buy)
|
6,250 |
| 2022-12-01 | Ly David H. |
Director, Chief Executive Officer |
Award↑
|
Options (Right to Buy)
|
15,000 |
| 2022-10-03 | Omi Gregory |
Chief Technology Officer |
Award↑
|
Options (Right to Buy)
|
5,000 |
| 2022-10-03 | BRILON ROBERT J |
Director, Chief Financial Officer |
Award↑
|
Options (Right to Buy)
|
5,000 |
| 2022-10-03 | Sung Chi-Kuang Sid |
President |
Award↑
|
Options (Right to Buy)
|
5 |
| 2022-10-03 | Franco Alejandro |
Director |
Award↑
|
Options (Right to Buy)
|
5,000 |
| 2022-10-03 | Berg Luz |
Chief Operating Officer |
Award↑
|
Options (Right to Buy)
|
5,000 |
| 2022-10-03 | Ly David H. |
Director, Chief Executive Officer |
Award↑
|
Options (Right to Buy)
|
5,000 |
| 2022-10-03 | Farnsworth Joseph A. |
Director |
Award↑
|
Options (Right to Buy)
|
5,000 |
| 2022-10-03 | Gillen Robert |
Director |
Award↑
|
Options (Right to Buy)
|
5,000 |
| 2022-06-15 | Berg Luz |
Chief Operating Officer |
Award↑
|
Options (Right to Buy)
|
10,000 |
| 2022-06-15 | BRILON ROBERT J |
Director, Chief Financial Officer |
Award↑
|
Options (Right to Buy)
|
10,000 |
| 2022-06-15 | Ly David H. |
Director, Chief Executive Officer |
Award↑
|
Options (Right to Buy)
|
12,500 |
| 2021-12-30 | BRILON ROBERT J |
Director, Chief Financial Officer |
Other↑
|
Options (Right to Buy)
|
200,000 |
| 2021-12-30 | Sung Chi-Kuang Sid |
President |
Award↑
|
Options (Right to Buy)
|
100,000 |
| 2021-12-30 | BRILON ROBERT J |
Director, Chief Financial Officer |
Convert↑
|
Common Stock
|
200,000 |